(Q31879923)

4 July 2017

title

Cardiovascular risk factors and LDL subfraction profile in Type 2 diabetes mellitus subjects with good glycaemic control (English)

1 reference

4 July 2017

1 reference

Tan CE

1

1 reference

4 July 2017

Chew LS

2

1 reference

4 July 2017

Chio LF

3

1 reference

4 July 2017

Tai ES

4

1 reference

4 July 2017

Lim HS

5

1 reference

4 July 2017

Lim SC

6

1 reference

4 July 2017

Jayakumar L

7

1 reference

4 July 2017

Eng HK

8

1 reference

4 July 2017

Packard CJ

9

1 reference

4 July 2017

publication date

1 February 2001

1 reference

Diabetes Research and Clinical Practice

4 July 2017

published in

1 reference

4 July 2017

volume

51

1 reference

4 July 2017

issue

2

1 reference

4 July 2017

page(s)

107-114

1 reference

Diabetes mellitus abolishes ethnic differences in cardiovascular risk factors: lessons from a multi-ethnic population

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

Small, dense low-density lipoprotein as a risk factor for coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

Differing α-Tocopherol Oxidative Lability and Ascorbic Acid Sparing Effects in Buoyant and Dense LDL

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

Relations Between Plasma Lipids and Postheparin Plasma Lipases and VLDL and LDL Subfraction Patterns in Normolipemic Men and Women

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

Greater effect of diabetes on LDL size in women than in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

LDL subclass phenotypes and the insulin resistance syndrome in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

Troglitazone decreases the proportion of small, dense LDL and increases the resistance of LDL to oxidation in obese subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2800%2900211-4

7 January 2021

10.1016/S0168-8227(00)00211-4

Identifiers

DOI

1 reference

4 July 2017

1 reference